Ricardo V. Lloyd, MD close
Ricardo V. Lloyd, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Ricardo V. Lloyd, MD Print Friendly Page

Dr. Lloyd earned his medical degree from the University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI and completed his residency at University of Wisconsin Hospital and Clinics.  He also completed his fellowship at University of Wisconsin Hospital and Clinics and Memorial Sloan-Kettering Cancer Center.  Dr. Lloyd is board certified in anatomic & clinical pathology and molecular genetic pathology.




University Hospital
(608) 263-8443 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Anatomic Pathology & Clinical Pathology
Molecular Genetic Pathology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Memorial Sloan-Kettering Cancer Center, New York, NY
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Chu YH Hardin H Eickhoff J Lloyd RV In Situ Hybridization Analysis of Long Non-coding RNAs MALAT1 and HOTAIR in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Pathol . 2019 Jan 2;
[PubMed ID: 30600442]
Carmona Matos DM Jang S Hijaz B Chang AW Lloyd RV Chen H Jaskula-Sztul R Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers. Surgery . 2019 Jan;165(1):64-68
[PubMed ID: 30415874]
Roy M Buehler DG Zhang R Schwalbe ML Baus RM Salamat MS Lloyd RV Rosenbaum JN Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites. Endocr Pathol . 2018 Dec 6;
[PubMed ID: 30523500]
Steward DL Carty SE Sippel RS Yang SP Sosa JA Sipos JA Figge JJ Mandel S Haugen BR Burman KD Baloch ZW Lloyd RV Seethala RR Gooding WE Chiosea SI Gomes-Lima C Ferris RL Folek JM Khawaja RA Kundra P Loh KS Marshall CB Mayson S McCoy KL Nga ME Ngiam KY Nikiforova MN Poehls JL Ringel MD Yang H Yip L Nikiforov YE Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol . 2018 Nov 8;
[PubMed ID: 30419129]
Lloyd RV The phrase NIFTP accentuates, rather than resolves, the current issues with thyroid neoplasia classification-reply. Hum Pathol . 2018 Sep;79:223
[PubMed ID: 29879401]
Hardin H Helein H Meyer K Robertson S Zhang R Zhong W Lloyd RV Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs. Lab Invest . 2018 Sep;98(9):1133-1142
[PubMed ID: 29967342]
Nikiforov YE Baloch ZW Hodak SP Giordano TJ Lloyd RV Seethala RR Wenig BM Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol . 2018 Aug 1;4(8):1125-1126
[PubMed ID: 29902314]
Guo Z Ge M Chu YH Asioli S Lloyd RV Recent Advances in the Classification of Low-grade Papillary-like Thyroid Neoplasms and Aggressive Papillary Thyroid Carcinomas: Evolution of Diagnostic Criteria. Adv Anat Pathol . 2018 Jul;25(4):263-272
[PubMed ID: 29762157]
Alves VAF Kakudo K LiVolsi V Lloyd RV Nikiforov YE Nosé V Papotti M Thompson LDR Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): Achieving Better Agreement By Refining Diagnostic Criteria. Clinics (Sao Paulo) . 2018 May 21;73:e576
[PubMed ID: 29791602]
Lloyd RV Asa SL LiVolsi VA Sadow PM Tischler AS Ghossein RA Tuttle RM Nikiforov YE The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Hum Pathol . 2018 Apr;74:1-4
[PubMed ID: 29339178]
Zhang R Hardin H Huang W Buehler D Lloyd RV Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma. Endocr Pathol . 2018 Mar;29(1):1-8
[PubMed ID: 29280051]
Rush PS Rosenbaum JN Roy M Baus RM Bennett DD Lloyd RV Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma). J Cutan Pathol . 2018 Feb;45(2):129-135
[PubMed ID: 29148079]
Lloyd RV McNicoll AM Annual review issue: An overview of 50 years of progress in endocrine pathology. Histopathology . 2018 Jan;72(1):4-5
[PubMed ID: 29239043]
Mandal R Hardin H Baus R Rehrauer W Lloyd RV Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms. Endocr Pathol . 2017 Dec;28(4):345-350
[PubMed ID: 29032398]
Ambrosi F Righi A Ricci C Erickson LA Lloyd RV Asioli S Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review. Endocr Pathol . 2017 Dec;28(4):293-301
[PubMed ID: 29019044]
Matson DR Hardin H Buehler D Lloyd RV AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion. Exp Mol Pathol . 2017 Dec;103(3):288-293
[PubMed ID: 29169802]
Hernandez-Prera JC Machado RA Asa SL Baloch Z Faquin WC Ghossein R LiVolsi VA Lloyd RV Mete O Nikiforov YE Seethala RR Suster S Thompson LD Turk AT Sadow PM Urken ML Wenig BM Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus? Thyroid . 2017 Dec;27(12):1498-1504
[PubMed ID: 29020884]
Chu YH Hardin H Schneider DF Chen H Lloyd RV MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. Exp Mol Pathol . 2017 Oct;103(2):229-236
[PubMed ID: 29107050]
Hardin H Zhang R Helein H Buehler D Guo Z Lloyd RV The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors. Lab Invest . 2017 Oct;97(10):1142-1151
[PubMed ID: 28394318]
Covach A Patel S Hardin H Lloyd RV Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm. Endocr Pathol . 2017 Sep;28(3):207-212
[PubMed ID: 28660408]